MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
QUICK SEARCH:   [advanced]


     

Molecular Pharmacology Fast Forward
First published on June 28, 2007; DOI: 10.1124/mol.107.034504

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.034504v1
72/4/826    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kosuge, K.
Right arrow Articles by Ito, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kosuge, K.
Right arrow Articles by Ito, S.


Received for publication January 29, 2007.
Revised June 28, 2007.
Accepted for publication June 28, 2007.

Discovery of Osmo-sensitive Transcriptional Regulation of Human Cytochrome P450 3As (CYP3As) by the Tonicity-Responsive Enhancer Binding Protein (TonEBP/ NFAT5)

Kazuhiro Kosuge 1, Andrew I Chuang 1, Satoko Uematsu 2, Kah Poh Tan 2, Kyoichi Ohashi 3, Ben CB Ko 4, Shinya Ito 2*

1 Hospital for Sick children 2 Hospital for Sick Children 3 Oita University 4 The Chinese University of Hong Kong, and the University of Hong Kong

* Address correspondence to: E-mail: shinya.ito{at}sickkids.ca

Abstract

We report the discovery of an osmo-sensitive transcriptional control of human CYP3A4, CYP3A7, and CYP3A5. Ambient hypertonicity (350 - 450 mOsm/kg) increased mRNA expressions of the CYP3As by ~10-20-fold in human-intestinal C2bbe1 cells, followed by an increase of CYP3A protein. Hypotonicity, on the other hand, suppressed CYP3A mRNA levels, indicating that physiological isotonic conditions may regulate the basal expression of CYP3A. Similar responses to ambient tonicity were observed in other human-derived cell lines (intestinal LS180, and hepatic HepG2) and human primary colonic cells. The 11-bp tonicity-responsive enhancer (TonE) is an osmo-sensitive regulator that is activated by the transcription factor, the nuclear factor of activated T-cells 5 (NFAT5). Luciferase-based reporter assays of 13 consensus TonE motifs within ±10kb from the transcription start sites of CYP3As showed that only the CYP3A7 intron 2 region (~5kb downstream from the transcription start site) which contains two TonE motifs (+5076/+5086 and +5417/+5427) was responsive to hypertonicity stimuli. This observation was confirmed upon cotransfection with an NFAT5 expression vector, siRNA or dominant-negative NFAT5. Deletion and mutation analyses suggested that the TonE (+5417/+5427) is indispensable for the enhancer activity. NFAT5 binding to the CYP3A7 intron 2 TonE motif was demonstrated with electrophoretic mobility shift assay and in a native cell context by chromatin immunoprecipitation. We conclude that transcription of the human CYP3As is influenced by ambient tonicity. The physiological significance of the tonic regulation of CYP3A enzymes remains to be determined.


Key words: NFAT, DNA binding sites, MDR/p-Glycoprotein, Regulation of gene expression, Cytochrome P450, Regulation - transcriptional


This article has been cited by other articles:


Home page
 PhysiologyHome page
M. S. Kwon, S. W. Lim, and H. M. Kwon
Hypertonic Stress in the Kidney: A Necessary Evil
Physiology, June 1, 2009; 24(3): 186 - 191.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics